Infertility is a disorder of the male and/or female reproductive system, characterized by failure to establish a clinical pregnancy after 12 months of regular unprotected sexual intercourse. On a world basis, about one in six couples, are affected by infertility during their reproductive lifespan. Despite a comprehensive diagnostic work-up, infertility in about 50% of couples remains idiopathic.

Our research group focuses on using omics approaches, particularly genomic methods, to identify the biological basis of this disease and improve diagnosis. In addition, our research group also focuses its attention on inositol, a carbocyclic sugar polyalcohol. Inositol is fundamental for signal transduction in the brain, kidneys, reproductive organs and other tissues in response to neurotransmitters, hormones and growth factors. Various genes are involved in inositol metabolism and associated pathways. Altered inositol concentrations are observed in several diseases. Analysis of the genes involved in inositol metabolism may provide important information for the clinical management of these conditions.

• “From Myo-inositol to D-chiro-inositol molecular pathways“;

• “Complications related to in vitro reproductive techniques support the implementation of natural procreative technologies“;

• “Breakthroughs in the Use of Inositols for Assisted Reproductive Treatment (ART)“;

• “A simultaneous next-generation sequencing approach to the diagnosis of couple infertility“;

• “Analysis of 29 Targeted Genes for Non-Obstructive Azoospermia: The Relationship between Genetic Testing and Testicular Histology”;

• “Dietary supplements for polycystic ovary syndrome”;
• “A simultaneous next-generation sequencing approach to the diagnosis of couple infertility”;

*“None of the reported studies or the patent can be used to claim the properties of dietary supplements. Dietary supplements do not possess any therapeutic or preventive properties.”